Westfuller Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585 Sell
3
-7
-70% -$1.45K ﹤0.01% 723
2026
Q1
$2.25K Buy
+10
New +$2.49K ﹤0.01% 621
2025
Q4
Sell
-13
Closed -$3.56K 808
2025
Q3
$3.56K Buy
+13
New +$3.55K ﹤0.01% 575

Other funds holding RMD

Westfuller Advisors's RMD Position: Q2 2026 in Review

Westfuller Advisors reduced its ResMed (RMD) stake by 70% in Q2 2026, selling an estimated $1.45K and leaving 3 shares worth $585. The position accounts for ﹤0.01% of the portfolio, ranked #723.

Westfuller Advisors first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.56K in Q3 2025. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Westfuller Advisors held 3 shares of ResMed worth $585 as of Q2 2026.
  • Westfuller Advisors sold 7 ResMed shares in Q2 2026, an estimated $1.45K.
  • ResMed made up ﹤0.01% of Westfuller Advisors's portfolio in Q2 2026, its #723 holding.
  • Westfuller Advisors first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Westfuller Advisors's ResMed position peaked at $3.56K in Q3 2025.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.